key: cord-1013795-zs9su1ze authors: Li, Kunwei; Liu, Xueguo; Yip, Rowena; Yankelevitz, David F.; Henschke, Claudia I.; Geng, Yayuan; Fang, Yijie; Li, Wenjuan; Pan, Cunxue; Chen, Xiaojun; Qin, Peixin; Zhong, Yinghua; Liu, Kunfeng; Li, Shaolin title: Early prediction of severity in coronavirus disease (COVID-19) using quantitative CT imaging date: 2021-02-10 journal: Clin Imaging DOI: 10.1016/j.clinimag.2021.02.003 sha: a2ddf8acc5d9ee1f1e540d1e2da5d8b8051a935a doc_id: 1013795 cord_uid: zs9su1ze PURPOSE: To evaluate whether the extent of COVID-19 pneumonia on CT scans using quantitative CT imaging obtained early in the illness can predict its future severity. METHODS: We conducted a retrospective single-center study on confirmed COVID-19 patients between January 18, 2020 and March 5, 2020. A quantitative AI algorithm was used to evaluate each patient's CT scan to determine the proportion of the lungs with pneumonia (VR) and the rate of change (RAR) in VR from scan to scan. Patients were classified as being in the severe or non-severe group based on their final symptoms. Penalized B-splines regression modeling was used to examine the relationship between mean VR and days from onset of symptoms in the two groups, with 95% and 99% confidence intervals. RESULTS: Median VR max was 18.6% (IQR 9.1–32.7%) in 21 patients in the severe group, significantly higher (P < 0.0001) than in the 53 patients in non-severe group (1.8% (IQR 0.4–5.7%)). RAR was increasing with a median RAR of 2.1% (IQR 0.4–5.5%) in severe and 0.4% (IQR 0.1–0.9%) in non-severe group, which was significantly different (P < 0.0001). Penalized B-spline analyses showed positive relationships between VR and days from onset of symptom. The 95% confidence limits of the predicted means for the two groups diverged 5 days after the onset of initial symptoms with a threshold of 11.9%. CONCLUSION: Five days after the initial onset of symptoms, CT could predict the patients who later developed severe symptoms with 95% confidence. later developed severe symptoms with 95% confidence. 【 key words 】 COVID-19; Prognosis; Tomography, X-ray computed; Quantitative evaluation; Deep learning 1. Introduction Coronavirus disease 2019 (COVID- 19) has rapidly increased in prevalence to become a global pandemic by March 2020 (1) . It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the United States, most professional organizations and societies recommend against the use of CT scanning for diagnostic evaluation even though it is accepted that CT findings can precede positive findings on reverse transcriptase polymerase chain reaction testing (RT-PCR) (2) . Early in the course of the pandemic, an editorial described the use of CT for diagnostic purposes as "a distraction" and "possibly dangerous" (3) . In addition, the utilization of CT will increase the risk of radiation exposure to the patient, risk of COVID-19 transmission to uninfected health people, and the consumption of personal protection equipment and downtime of CT scanning rooms. However, both for diagnostic purposes and also for follow-up, other countries, notably China, routinely obtain CT scans on all proven positive cases (4) . The radiologic features of COVID-19 have been well described and include features similar to those found in organizing pneumonia with peripheral ground glass opacities (GGOs) that are bilateral, multi-lobar, nodular and mass-like with a basilar predilection (5) . There are also many additional, more non-specific features (6) . The general time course for the radiologic findings of COVID-19 has been described (7, 8, 9) . GGOs can usually be found within the first 4-5 days of initial symptom presentation and peak between 6-13 days. In China, four categories of severity of COVID-19 disease have also been described in the Diagnosis and Treatment Plan of COVID-19 issued by National Health Commission (7th ed.) (9) . The four categories are: [1] mild type defined as having mild clinical symptoms without pneumonia in imaging; [2] common type defined by having fever, respiratory tract and other symptoms, pneumonia on imaging; [3] severe type defined as having respiratory distress, respiratory rate≥30 times/min, oxygen saturation≤93%, PaO 2 /FiO 2 ≤300mmHg; [4] critical type defined by respiratory failure requiring mechanical ventilation, shock, other organ failure, ICU monitoring and treatment. In managing patients with COVID-19, the ability to predict in the first few days after onset of symptoms which patients will ultimately progress into the severe or critical category would be highly useful for management and planning purposes. It would allow for planning on the likelihood of more intensive treatment, possibly assisted ventilation and similarly, who will likely need only minor supportive care. Based on the use of CT scans of patients with confirmed COVID-19 diagnosis, the goal was to evaluate the extent to which early quantitative CT findings are useful to predict the extent of disease progression prior to reaching the severe stage. A retrospective, single-center study was performed of SARS-CoV-2 laboratory-confirmed patients between January 18, 2020 and March 5, 2020 in Zhuhai, China. A patient was confirmed as positive by high-throughput sequencing or real-time RT-PCR assay (10) (Shanghai Zhijiang Biotechnology Co. Shanghai, China) and confirmed by the Centers for Disease Control. This study was approved by the institutional review board of the [BLINDED] J o u r n a l P r e -p r o o f and requirement for informed consent was waived. CT imaging features in some patients included in this study have been previously reported (5, 8, 11) but not on AI quantitative CT parameters presented here. Inclusion criteria were patients with: (a)positive new coronavirus nucleic acid antibody; (b)age≥14; (c)≥2 consecutive thin-section CT scans within seven days; (d)clinical symptoms of COVID-19; and (e)pneumonia on at least one CT examination. Only patients who met all inclusion criteria listed above were included in this study. Patients with CT scans with obvious alternative diagnoses were excluded. Symptoms were obtained by chart review. COVID-19 disease severity categories of [2-common] , [3-severe] , and [4-critical] were aggregated into two at discharge according to the most severe category at any time during their admission: the non-severe group which included all patients with COVID-19 category [2-common] and the severe group which included all patients who developed COVID-19 categories [3-severe] and [4-critical] . All scans were performed with patients in the supine position during end-inspiration without intravenous contrast on three CT scanners, uCT 760, uMI 780 scanners (United Imaging; Shanghai, China) and Precision 32(CAMPO Imaging; Shenyang, China). Images were obtained from the apex to lung bases. Scans were obtained using a standard dose protocol, reconstructed at 1.0mm/1.1mm slice thickness with 0.7mm increment, 512mm×512mm matrix and a sharp reconstruction kernel. Lung window width and level settings were 1500 Hounsfield units (HU) and -600HU. A deep learning-based algorithm (HY Medical Technology) trained on annotated datasets of COVID-19 was used to segment and quantify the total volume of both lungs (TV) and the total volume of the lesions presumed to represent COVID-19 pneumonia (e.g., GGOs, consolidation) (DV) for each patient. Detailed information about the deep learning algorithm and structure has been previously described (12, 13) . The determination of TV and DV was made using the software and accuracy was reviewed by two radiologists with 5-and 3-years of experience [BLINDED] . In cases where the software failed to provide the TV and DV estimates, estimates were visually estimated by a third radiologist with 17 years of experience [BLINDED] . For each patient, the following values were calculated for each CT scans using the quantitative parameters (TV and DV) derived from the AI assessments: 1. Volume Ratio (VR)=DV/TV, the ratio of CT volume of all infected lung regions to the whole lung volume. 2. Ratio Alteration Rate (RAR)=(VR 2 -VR 1 )/days, the change in VR from time 1 (VR 1 ) to time 2 (VR 2 ), divided by days between the two CT scans. 3. Maximum volume ratio (VR max ) was the highest VR attained among all CT scans for the particular patient and the day it was reached was D max . We defined two disease phases based on the CT scans, the progressive and recovery phases. For each patient, the CT scan was classified as: Being in the progressive phase, if VR≤VR max , RAR was positive, and the date of the CT scan was on or before D max and Being in the recovery phase: if VR